Tumor Etiology and Screening, Department of Cancer Institute and General Surgery, The First Affiliated Hospital of China Medical University, Key Laboratory of Cancer Etiology and Prevention, China Medical University, Liaoning Provincial Education Department, Shenyang 110001, China.
Biosci Rep. 2021 Jan 29;41(1). doi: 10.1042/BSR20203481.
Mitochondria-nuclear cross-talk and mitochondrial retrograde regulation are involved in the genesis and development of breast cancer (BC). Therefore, mitochondria can be regarded as a promising target for BC therapeutic strategies. The present study aimed to construct regulatory network and seek the potential biomarkers of BC diagnosis and prognosis as well as the molecular therapeutic targets from the perspective of mitochondrial dysfunction.
The microarray data of mitochondria-related encoding genes in BC cell lines were downloaded from GEO including GSE128610 and GSE72319. GSE128610 was treated as test set and validation sets consisted of GSE72319 and TCGA tissue samples, intending to identify mitochondria-related differentially expressed genes (mrDEGs). We performed enrichment analysis, PPI network, hub mrDEGs and overall survival analysis and constructed transcription factor (TF)-miRNA-hub mrDEGs network.
A total of 23 up-regulated and 71 down-regulated mrDEGs were identified and validated in BC cell lines and tissues. Enrichment analyses indicated that mrDEGs were associated with several cancer-related biological processes. Moreover, 9 hub mrDEGs were identified and validated in BC cell lines and tissues. Finally, 5 hub coregulated mrDEGs, 21 miRNAs and 117 TFs were used to construct TF-miRNA-hub mrDEGs network. MYC associated zinc finger protein (MAZ), heparin binding growth factor (HDGF) and Sp2 transcription factor (SP2) regulated 3 hub mrDEGs. Hsa-mir-21-5p, hsa-mir-1-3p, hsa-mir-218-5p, hsa-mir-26a-5p and hsa-mir-335-5p regulated 2 hub mrDEGs. Overall survival analysis suggested that the up-regulation of fibronectin 1 (FN1), as well as the down-regulation of discoidin domain receptor tyrosine kinase 2 (DDR2) correlated with unfavorable prognosis in BC.
TF-miRNA-hub mrDEGs had instruction significance for the exploration of BC etiology. The hub mrDEGs such as FN1 and DDR2 were likely to regulate mitochondrial function and be novel biomarkers for BC diagnosis and prognosis as well as the therapeutic targets.
线粒体-核串扰和线粒体逆行调节参与乳腺癌(BC)的发生和发展。因此,线粒体可以被视为 BC 治疗策略的一个有前途的靶点。本研究旨在从线粒体功能障碍的角度构建调控网络,并寻找潜在的 BC 诊断和预后的生物标志物以及分子治疗靶点。
从 GEO 下载了包括 GSE128610 和 GSE72319 在内的与线粒体相关编码基因的 BC 细胞系的微阵列数据。GSE128610 被视为测试集,验证集由 GSE72319 和 TCGA 组织样本组成,旨在鉴定与线粒体相关的差异表达基因(mrDEGs)。我们进行了富集分析、PPI 网络、hub mrDEGs 和总生存分析,并构建了转录因子(TF)-miRNA-hub mrDEGs 网络。
在 BC 细胞系和组织中鉴定和验证了 23 个上调和 71 个下调的 mrDEGs。富集分析表明,mrDEGs 与几种癌症相关的生物学过程有关。此外,在 BC 细胞系和组织中鉴定了 9 个 hub mrDEGs。最后,构建了 TF-miRNA-hub mrDEGs 网络,包含 5 个 hub 核心调控 mrDEGs、21 个 miRNA 和 117 个 TF。MAZ、HDGF 和 SP2 转录因子调节 3 个 hub mrDEGs。hsa-mir-21-5p、hsa-mir-1-3p、hsa-mir-218-5p、hsa-mir-26a-5p 和 hsa-mir-335-5p 调节 2 个 hub mrDEGs。总生存分析表明,FN1 的上调以及 DDR2 的下调与 BC 的不良预后相关。
TF-miRNA-hub mrDEGs 对探索 BC 病因具有指导意义。FN1 和 DDR2 等 hub mrDEGs 可能调节线粒体功能,成为 BC 诊断和预后以及治疗靶点的新的生物标志物。